An open-label study to evaluate the extended early bactericidal activity, safety, tolerability and pharmacokinetics of multiple oral doses of TMC207 [R 207910] in treatment-naive subjects with sputum smear positive for pulmonary tuberculosis.
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2010
At a glance
- Drugs Bedaquiline; Isoniazid; Rifampicin
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 19 Oct 2007 Status changed from in progress to completed.
- 08 Sep 2007 New trial record.